Institut De Médecine Et D'epidémiologie Appliquée - Fondation Internationale Léon M'ba

This was a planned phase 2 study to test a combination of two long-acting drugs, cabotegravir and lenacapavir, for people with HIV who have tried many treatments. The goal was to see if switching to these injections every two months could keep the virus under control. However, th…